Association of Predicted Damaging De Novo Variants on Ventricular Function in Individuals With Congenital Heart Disease
Matthew Lewis(Columbia University Irving Medical Center), Wendy K. Chung(Oregon Health & Science University), Lu Qiao(University of Electronic Science and Technology of China), Elizabeth Goldmuntz(Children's Hospital of Philadelphia), J. William Gaynor(Children's Hospital of Philadelphia), Brigitte Kazzi(Johns Hopkins Hospital), Alexander Hsieh(Columbia University), Yufeng Shen(Columbia University Irving Medical Center), Vaidehi Jobanputra(Columbia University Irving Medical Center), Jane W. Newburger(Oregon Health & Science University), Martin Tristani‐Firouzi(University of Utah), Lazaros Kochilas(Emory Healthcare), Alexandra Channing(Columbia University Irving Medical Center), Seema Mital(University of Toronto), Emily Griffin(Columbia University), Jennifer Su(Children's Hospital of Los Angeles), Shahryar M. Chowdhury(Medical University of South Carolina), Mark W. Russell(Andover Eye Associates), Martina Brueckner(Yale University), Teresa Lee(Imperial College London), Renjie Tan(Kunming University of Science and Technology)
Cited by 4
Related Papers
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
|Circulation|2017|3.7k
Prevention of Infective Endocarditis
|Circulation|2007|2.8k
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
|Circulation|2004|1.9k
The support of human genetic evidence for approved drug indications
|Nature Genetics|2015|1.8k